121 studies found for:    Sjögren's Syndrome
Show Display Options
Rank Status Study
21 Recruiting Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Procedure: Sialoendoscopy;   Drug: saline;   Drug: hydrocortisone
22 Completed Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Belimumab
23 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
24 Completed Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
Conditions: Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention: Drug: Dehydroepiandrosterone
25 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
26 Recruiting Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Abatacept SC
27 Terminated
Has Results
Pilot Study of Raptiva to Treat Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Raptiva
28 Completed The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
Condition: Sjogren's Syndrome
Intervention:
29 Completed A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
Conditions: Dry Eye Syndromes;   Sjögren Syndrome
Intervention:
30 Completed Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
Condition: Sjögren's Syndrome Patients With Severe Dry Eye
Interventions: Drug: 0.02% Fm, SH;   Drug: 0.02% Fm, SH, 0.05% CsA;   Other: 0.02% Fm, SH, tBCL;   Drug: 0.02% Fm, SH, AS
31 Completed Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: LimphoStat-B
32 Withdrawn Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736 lower dose;   Drug: VAY736 higher dose
33 Not yet recruiting the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
34 Enrolling by invitation Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
35 Completed Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
Conditions: Xerostomia;   Sjogren's Syndrome
Intervention: Drug: NGX267
36 Active, not recruiting Aerobic Exercise in Primary Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Other: aerobic exercise
37 Completed Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjogren's Syndrome;   Xerostomia;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
38 Enrolling by invitation Salivary Biomarkers for Sjögren's Syndrome Detection
Condition: Sjögren's Syndrome
Intervention:
39 Completed Exploratory Study for Dry Mouth in Patients With Sjögren’s Syndrome
Conditions: Xerostomia;   Sjogren's Syndrome
Intervention: Drug: Rebamipide
40 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years